RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript
RxSight, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.36.
Source: insidermonkey.com
Page 4 - Refractive Surgery News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Refractive Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Refractive Surgery Today - Breaking & Trending Today
IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial...
Source: pr.com
2024 Will See Major Advances in Glaucoma Care
Three new treatments for dry eye disease and a new procedure and remote monitoring platform for glaucoma are due to debut in 2024, with more in the pipeline.
Source: medscape.com
Corneal Topographers Market Projected to Reach USD 1,258.52
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments
Stuart Therapeutics, Inc. ("Stuart"), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today an
Source: newswise.com